Search Results

***REFERRAL ONLY*** A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

Caris Retrospective Real-world Outcomes-Associated Database, Multi-site Precision Oncology Alliance Protocol (ROADMAP)

Caris Prospective Real-world Outcomes-Associated Database, Multi-site Precision Oncology Alliance Protocol (pROADMAP)

A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF Class 1 and Class 2 alterations, in participants with cancer harboring BRAF alterations

The Caris Biorepository Research Protocol

An Open-Label, Multicenter, First-in-Human, Dose-Escalation and Dose-Expansion, Phase 1/2 Study of BBI-355 and BBI-355 in Combination with Select Targeted Therapies in Subjects with Locally Advanced or Metastatic Solid Tumors with Oncogene Amplifications.